mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.2 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.5 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.5 |